Meta-analysis of Cancer Gene Expression Signatures Reveals New Cancer Genes, SAGE Tags and Tumor Associated Regions of Co-regulation

Overview

Journal Nucleic Acids Res

Publisher Oxford University Press

Specialty Biochemistry

Date 2010 Jul 13

PMID 20621981

Citations 13

Authors

Ersen Kavak

Mustafa Unlu

Monica Nister

Ahmet Koman

Affiliations

Soon will be listed here.

Abstract

Cancer is among the major causes of human death and its mechanism(s) are not fully understood. We applied a novel meta-analysis approach to multiple sets of merged serial analysis of gene expression and microarray cancer data in order to analyze transcriptome alterations in human cancer. Our methodology, which we denote 'COgnate Gene Expression patterNing in tumours' (COGENT), unmasked numerous genes that were differentially expressed in multiple cancers. COGENT detected well-known tumor-associated (TA) genes such as TP53, EGFR and VEGF, as well as many multi-cancer, but not-yet-tumor-associated genes. In addition, we identified 81 co-regulated regions on the human genome (RIDGEs) by using expression data from all cancers. Some RIDGEs (28%) consist of paralog genes while another subset (30%) are specifically dysregulated in tumors but not in normal tissues. Furthermore, a significant number of RIDGEs are associated with GC-rich regions on the genome. All assembled data is freely available online (www.oncoreveal.org) as a tool implementing COGENT analysis of multi-cancer genes and RIDGEs. These findings engender a deeper understanding of cancer biology by demonstrating the existence of a pool of under-studied multi-cancer genes and by highlighting the cancer-specificity of some TA-RIDGEs.

Citing Articles

Transcriptome profiling and analysis of patients with esophageal squamous cell carcinoma from Kazakhstan.

Sharip A, Rakhimova S, Molkenov A, Ashenova A, Kozhamkulov U, Akhmetollayev I Front Genet. 2024; 15:1249751.

PMID: 38562378 PMC: 10982404. DOI: 10.3389/fgene.2024.1249751.

Replication-dependent histone isoforms: a new source of complexity in chromatin structure and function.

Singh R, Bassett E, Chakravarti A, Parthun M Nucleic Acids Res. 2018; 46(17):8665-8678.

PMID: 30165676 PMC: 6158624. DOI: 10.1093/nar/gky768.

Knockdown of ribosomal protein S15A inhibits proliferation of breast cancer cells through induction of apoptosis in vitro.

Feng W, Liang C, Wang C, Yu X, Li Q, Yang H Cytotechnology. 2018; 70(5):1315-1323.

PMID: 29802490 PMC: 6214850. DOI: 10.1007/s10616-018-0221-9.

Identification of a gene signature for discriminating metastatic from primary melanoma using a molecular interaction network approach.

Metri R, Mohan A, Nsengimana J, Pozniak J, Molina-Paris C, Newton-Bishop J Sci Rep. 2017; 7(1):17314.

PMID: 29229936 PMC: 5725601. DOI: 10.1038/s41598-017-17330-0.

Histone isoform H2A1H promotes attainment of distinct physiological states by altering chromatin dynamics.

Bhattacharya S, Reddy D, Jani V, Gadewal N, Shah S, Reddy R Epigenetics Chromatin. 2017; 10(1):48.

PMID: 29047414 PMC: 5648446. DOI: 10.1186/s13072-017-0155-z.

References

Versteeg R, van Schaik B, Van Batenburg M, Roos M, Monajemi R, Caron H . The human transcriptome map reveals extremes in gene density, intron length, GC content, and repeat pattern for domains of highly and weakly expressed genes. Genome Res. 2003; 13(9):1998-2004. PMC: 403669. DOI: 10.1101/gr.1649303. View

Hendrix M, Seftor E, Seftor R, Gardner L, Boldt H, Meyer M . Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers. Lab Invest. 1998; 78(2):153-63. View

Moenner M, Pluquet O, Bouchecareilh M, Chevet E . Integrated endoplasmic reticulum stress responses in cancer. Cancer Res. 2007; 67(22):10631-4. DOI: 10.1158/0008-5472.CAN-07-1705. View

Boon K, Osorio E, Greenhut S, Schaefer C, Shoemaker J, Polyak K . An anatomy of normal and malignant gene expression. Proc Natl Acad Sci U S A. 2002; 99(17):11287-92. PMC: 123249. DOI: 10.1073/pnas.152324199. View

Xu L, Geman D, Winslow R . Large-scale integration of cancer microarray data identifies a robust common cancer signature. BMC Bioinformatics. 2007; 8:275. PMC: 1950528. DOI: 10.1186/1471-2105-8-275. View

Morrissy A, Morin R, Delaney A, Zeng T, McDonald H, Jones S . Next-generation tag sequencing for cancer gene expression profiling. Genome Res. 2009; 19(10):1825-35. PMC: 2765282. DOI: 10.1101/gr.094482.109. View

Ge X, Yamamoto S, Tsutsumi S, Midorikawa Y, Ihara S, Wang S . Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics. 2005; 86(2):127-41. DOI: 10.1016/j.ygeno.2005.04.008. View

Diederichs S, Bulk E, Steffen B, Ji P, Tickenbrock L, Lang K . S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Cancer Res. 2004; 64(16):5564-9. DOI: 10.1158/0008-5472.CAN-04-2004. View

Zhang Y, Feng Y, Shen X, Chen B, Du X, Luo M . Exogenous expression of Esophagin/SPRR3 attenuates the tumorigenicity of esophageal squamous cell carcinoma cells via promoting apoptosis. Int J Cancer. 2007; 122(2):260-6. DOI: 10.1002/ijc.23104. View

10.

Rhodes D, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D . Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci U S A. 2004; 101(25):9309-14. PMC: 438973. DOI: 10.1073/pnas.0401994101. View

11.

Martin N, Patel S, Segre J . Long-range comparison of human and mouse Sprr loci to identify conserved noncoding sequences involved in coordinate regulation. Genome Res. 2004; 14(12):2430-8. PMC: 534667. DOI: 10.1101/gr.2709404. View

12.

Rhodes D, Kalyana-Sundaram S, Mahavisno V, Barrette T, Ghosh D, Chinnaiyan A . Mining for regulatory programs in the cancer transcriptome. Nat Genet. 2005; 37(6):579-83. DOI: 10.1038/ng1578. View

13.

Stransky N, Vallot C, Reyal F, Bernard-Pierrot I, Gil Diez de Medina S, Segraves R . Regional copy number-independent deregulation of transcription in cancer. Nat Genet. 2006; 38(12):1386-96. DOI: 10.1038/ng1923. View

14.

Mitchell J, Aronson A, Mork J, Folk L, Humphrey S, Ward J . Gene indexing: characterization and analysis of NLM's GeneRIFs. AMIA Annu Symp Proc. 2004; :460-4. PMC: 1480312. View

15.

Miller T, Lippman S, Spier C, Slymen D, Grogan T . HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma. J Clin Invest. 1988; 82(1):370-2. PMC: 303519. DOI: 10.1172/JCI113598. View

16.

Bueno-de-Mesquita J, van Harten W, Retel V, J van t Veer L, van Dam F, Karsenberg K . Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER). Lancet Oncol. 2007; 8(12):1079-1087. DOI: 10.1016/S1470-2045(07)70346-7. View

17.

Marsman M, Jordens I, Griekspoor A, Neefjes J . Chaperoning antigen presentation by MHC class II molecules and their role in oncogenesis. Adv Cancer Res. 2005; 93:129-58. DOI: 10.1016/S0065-230X(05)93004-2. View

18.

Costantini M, Clay O, Auletta F, Bernardi G . An isochore map of human chromosomes. Genome Res. 2006; 16(4):536-41. PMC: 1457033. DOI: 10.1101/gr.4910606. View

19.

Cohen B, Mitra R, Hughes J, Church G . A computational analysis of whole-genome expression data reveals chromosomal domains of gene expression. Nat Genet. 2000; 26(2):183-6. DOI: 10.1038/79896. View

20.

Xu L, Shen S, Hoshida Y, Subramanian A, Ross K, Brunet J . Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases. Mol Cancer Res. 2008; 6(5):760-9. PMC: 2756991. DOI: 10.1158/1541-7786.MCR-07-0344. View